Injectable Thermosensitive Nanocomposites Based on Poly( N -vinylcaprolactam) and Silica Particles for Localized Release of Hydrophilic and Hydrophobic Drugs
Langmuir · 14.02.2023 · 39 (6) · 2380-2388
DOI: 10.1021/acs.langmuir.2c03160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Langmuir, online erschienen am 06.02.2023. Verfasst von Lucas S Ribeiro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Laboratory of Electrochemistry and Ceramics (LIEC), Departament of Chemistry, Federal University of São Carlos (UFSCar), Rod. Washi…. Hauptthemen laut MEDLINE: Silicon Dioxide, Nanocomposites. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
The systemic delivery of drugs employed by conventional methods has shown to be less effective than a localized delivery system. Many drugs have the effectiveness reduced by fast clearance, increasing the amount required for an efficient treatment. One way to overcome this drawback is through the use of thermoresponsive polymers that undergo a sol-gel transition at physiological temperature, allowing their injection directly in the desired site. In this work, thermosensitive nanocomposites based on poly(N-vinylcaprolactam) and silica particles with 80 and 330 nm were synthesized to be employed as delivery systems for hydrophobic (naringin) and hydrophilic (doxorubicin hydrochloride) drugs. The insertion of SiO2 increased the rheological properties of the nanocomposite at 37 °C, which helps to prevent its diffusion away from the site of injection. The synthesized materials were also able to control the drug release for a period of 7 days under physiological conditions. Due to its higher hydrophobicity and better interaction with the PNVCL matrix, naringin presented a more controlled release. The Korsmeyer-Peppas model indicated different release mechanisms for each drug. At last, a preliminary in vitro study of DOX-loaded nanocomposites cultured with L929 and MB49 cells showed negligible toxic effects on healthy cells and better efficient inhibition of carcinoma cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Laboratory of Electrochemistry and Ceramics (LIEC), Departament of Chemistry, Federal University of São Carlos (UFSCar), Rod. Washington Luis km 235, CP 676 São Carlos, São Paulo 13565-905, Brazil.
- Laboratory of Applied Immunology, Federal University of São Carlos (UFSCar), São Carlos, Rod. Washington Luis km 235, CP 676 São Carlos, São Paulo 13565-905, Brazil.
ORCID-Profile: Lucas S Ribeiro, Renata L Sala, Thaiane A Robeldo
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Ribeiro, L. S., Sala, R. L., Robeldo, T. A., Borra, R. C., & Camargo, E. R. (2023). Injectable Thermosensitive Nanocomposites Based on Poly( N -vinylcaprolactam) and Silica Particles for Localized Release of Hydrophilic and Hydrophobic Drugs. Langmuir, 39(6), 2380-2388. https://doi.org/10.1021/acs.langmuir.2c03160
Vancouver
Ribeiro LS, Sala RL, Robeldo TA, Borra RC, Camargo ER. Injectable Thermosensitive Nanocomposites Based on Poly( N -vinylcaprolactam) and Silica Particles for Localized Release of Hydrophilic and Hydrophobic Drugs. Langmuir. 2023;39(6):2380-2388. doi:10.1021/acs.langmuir.2c03160
BibTeX
@article{Ribeiro2023,
author = {Ribeiro, Lucas S and Sala, Renata L and Robeldo, Thaiane A and Borra, Ricardo C and Camargo, Emerson R},
title = {Injectable Thermosensitive Nanocomposites Based on Poly( N -vinylcaprolactam) and Silica Particles for Localized Release of Hydrophilic and Hydrophobic Drugs},
journal = {Langmuir},
year = {2023},
volume = {39},
number = {6},
pages = {2380--2388},
doi = {10.1021/acs.langmuir.2c03160}
}
EUVIMED